MedTrace Logo

Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer

NCT03592004 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-07-19

No results posted yet for this study

Summary

This is a single-arm, multicentre study that aims to assess whether Radiomics combining multiparametric MRI and clinical data could be a good predictor of the responses to neoadjuvant chemotherapy in Breast Cancer.

Conditions

  • Breast Cancer
  • Radiomics
  • Neoadjuvant Chemotherapy
  • Multi-parametric MRI

Interventions

OTHER

neoadjuvant chemotherapy

neoadjuvant chemotherapy

Sponsors & Collaborators

  • Guangdong Provincial People's Hospital

    collaborator OTHER

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    collaborator OTHER

  • Beijing Friendship Hospital

    collaborator OTHER

  • Yunnan Cancer Hospital

    collaborator OTHER

  • Liaoning Cancer Hospital & Institute

    collaborator OTHER

  • First Hospital of China Medical University

    collaborator OTHER

  • Affiliated Hospital of Hebei University

    collaborator OTHER

  • Chinese Academy of Sciences

    lead OTHER_GOV

Principal Investigators

  • Jie Tian, Doctor · Chinese Academy of Sciences

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-18
Primary Completion
2019-06-01
Completion
2022-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03592004 on ClinicalTrials.gov